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Studies performed in a  number of laboratories have clearly shown  that alloanti- 
bodies directed at target cell antigens can prevent their recognition and subsequent 
destruction by effector cells specifically sensitized to them  (1-3). This type of block- 
ing has been taken as a  partial explanation for enhancement phenomena of progres- 
sively growing tumors  (4,  5) and for success of transplanted tissue in allogeneic re- 
cipients (6, 7). On the other hand, attempts at achieving a blockade of cellular recogni- 
tion processes with alloantibodies against effector cell-surface components have met 
with less clear success. Ramseier and Lindenmann  (8)  have described a  method for 
the production of an antireceptor site antiserum, which functions to prevent the re- 
lease of a "product of antigen recognition" (PAR),  1 a leukotactic factor released when 
allogeneic cells are mixed in culture (9). This antiserum was  tested in a  number of 
different laboratories and  reported by Lindahl  (10)  to  have  no  apparent effect on 
proliferation in mixed leukocyte culture (MLC), survival of skin or heart allografts, 
expression of cell-mediated cytotoxicity in vitro, or graft-vs.-host (GvH) reactivity. 
The fact that this antiserum is ineffective in  blocking such  known  T-cell functions 
raises some doubt as to its apparent specificity. 
In  the  present  study,  a  method  for  the  production  of  specific anti-T-cell 
receptor  antiserum  is  presented,  together  with  experimental  data  demon- 
strating its ability to block specific cell-mediated cytotoxicity in vitro. The basis 
for the production of this antiserum involves the immunization of rabbits with 
C3H  anti-BALB/c effector cells, and  the  subsequent  adsorption of this anti- 
serum with  C3H  anti-C57BL/6  effector cells. The resultant antiserum is able 
to discriminate C3H anti-BALB/c effector cells from other mouse lymphocytes. 
Materials  and  Methods 
Animals.--Inbred  strains of mice (C3H, C57BL/6,  BALB/c, and DBA/2) were obtained 
from  either Jackson  Laboratories (Bar  Harbor,  Me.)  or  Microbiological  Associates,  Inc., 
* Supported in part by NIH Research Grant HD-06071, American Cancer Society Research 
Grant IC-I4, and Damon Runyon, DRE-1190  to Dr. W. R. Clark. 
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1 Abbrevlat¢om used in this paper: AS, rabbit anti-(C3H anti-BALB/c effector cell) anti- 
serum; C  r, complement from reconstituted guinea pig serum; CMC, cell-mediated cytotoxicity; 
FCS, fetal calf serum;  GvH, graft-vs.-host reactivity; MLC, mixed leukocyte culture; NRS, 
normal rabbit serum;  PAR, product of antigen recognition;  PBS, phosphate-buffered  saline. 
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(Bethesda, Md.). Both male and female mice 6-10 wk of age were used in this study. Outbred 
white rabbits were obtained from local breeders. 
Sera and Reagents.--The same lot of lyophilized guinea pig serum was used as the source of 
complement (C') for the entire study. C' was reconstituted just before each experiment and 
diluted to the appropriate concentration with cold phosphate-buffered saline (PBS). All test 
and control sera were C' inactivated by heating in a 56°C water bath for 30 min, and stored 
frozen at -  10°C. 
Source of Immune  Cdls.--In vivo-sensitized effector cells were obtained from spleens of 
lethally irradiated (850 R) mice which were injected i.v. 5-6 days previously with 5.0 ×  10 ~ 
allogeneic (C3H) lymphocytes (11).  In vitro-sensitized effector ceils were generated in MLC 
as described previously  2. 
Cell-Mediated Cytotoxicity Testing.---Cell-mediated cytotoxicity  (CMC)  was  determined 
against appropriate 51Cr-labeled tumor cells in suspension assay essentially according to Canty 
and  Wunderlich  (12),  modified for  microassay  as  described  previously  (11).  Effector  cell 
preparations were suspended to a concentration of 10 ~ cells/ml in Dulbecco's modified Eagle's 
minimal essential medium pins 5% heat-inactvated fetal calf serum (FCS). 50/zl of this cell 
suspension was mixed with 25 #1 of the appropriate test serum (rabbit anti-[C3H anti-BALB/c 
effector cell] antiserum [AS] or normal rabbit serum [NRS])  at various dilutions. This mixture 
was then incubated in Falcon 3040 Microtest II wells  (Falcon Plastics,  Div.  of BioQuest, 
Oxnard, Calif.) for 1-2 h at 4°C before the addition of the ~lCr-labeled target cells. The total 
volume of the assay mixture was 85 #1 with an effector to target cell ratio of 50:1. At the end 
of 4 h of incubation with rocking (12) at 37°C in a humidified atmosphere of 7.5% CO2 in air, 
0.1 ml of cold PBS was added to each well. This mixture plus additional wash (0.25 ml PBS) 
was transfered to Falcon tubes (no. 2051)  containing 1.0 ml of PBS. The tubes were vortexed 
lightly and centrifuged at 600 g for 5 rain. 1-ml aliquots of the supernates were removed and 
counted in a gamma scintillation spectrometer. Percent 51Cr released was determined accord- 
ing to Bruuner et al. (1) : 
Cpm released, exp.  -- cpm released, control 
X  100. 
Total cpm -- cpm released, control 
Total  5tCr-released was determined by  osmotic lysis of the target cells in distilled water, 
which was at least as effective as repeated freeze-thaw procedures. 
Immunization Pratocols.--Rabbits were immunized i.v. with 6.5 X  10  s C3H anti-BALB/c 
spleen ceils in PBS. Red blood ceils were removed before injection by treating the spleen cell 
suspensions with 0.85% Tris-buffered NH4C1 according to Boyle (13) and washed twice with 
PBS. 10 days following the primary injection, the rabbits were boosted with 4.3 X  10  s immune 
cells.  The rabbits were bled 1 wk after the second challenge. The serum was collected, steri- 
lized by filtration, and stored in aliquots at --10°C. 
Adsorption  Protocols.--All  adsorptions  of  undiluted,  heat-inactivated  antiserum  were 
carried out at a ratio of 1:1 (antiserum:packed cells) for 45 min on ice. Either NH4Cl-treated 
BALB/c spleen ceils or the DBA/2  (H-2  b) mastocytoma, P815-X2, were equally effective in 
removing anti-BALB/c C'-fixing antibodies, and were both used as adsorbing cells during the 
course of these studies. Likewise, C57BL/6 spleen ceils or the syngeneie leukosis, EL4, could 
be  used  interchangeably  as  adsorbing  cells.  Adsorptions  with  immune  cells  (C3H 
anti-C57BL/6) were carried out as with the normal or tumor cells.  Immune cells were ob- 
tained from spleens of  GVH recipients,  treated with NI-I4C1, and washed twice with PBS 
before the adsorption. 
2 Kimura, A. K., and W. Clark. 1974. Functional characteristics of T-cell receptors during 
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RESULTS 
The high degree of immunological specificity seen in the destructive phase of 
cellular immune responses (14, 15) suggests possible qualitative differences in 
the macromolecular architecture of cell-surface recognition units present  on 
effector cell  populations.  It  has  been  demonstrated  2 that  C3H  lymphocytes 
undergoing sensitization to either BALB/c (H-2 '~) or C57BL/6 (tt-2 b) exhibit 
strain-specific recognition and target cell destruction of the sensitizing strain, 
from the beginning of measurable effector cell function till the generation of full 
cytotoxicity. 
The rationale employed in raising a specific  rabbit anti (C3H receptors for 
BALB/c) antiserum is schematically depicted in Fig. 1. If antiserum could be 
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Protocol for the production of rabbit anti-(C3H receptors for BALB/c) antiserum. 
successfully raised against  the cell-surface components of C3H effector ceils 
immune to BALB/c, antibodies directed against recognition structures would 
hopefully be represented within this antiserum. Removal of other species, strain, 
effector or  blast  cell  antigen-directed antibodies  could  be  accomplished  by 
adsorbing the antiserum with C3H anti-C57BL/6  effector cells. The resulting 
antiserum should be predominantly if not exclusively directed against the recep- 
tor units which distinguish the immunological reactivity of these two syngeneic 
effector cell populations. 
Since the C3H effector cells used for immunization of the rabbits were derived 
from spleens of lethally irradiated BALB/c hosts undergoing GvH sensitiza- 
tion, some BALB/c cells were likely included in the original sensitizing inocu- ARTHUR  K.  KII~URA  89l 
lure.  Thus,  antibodies  against  BALB/c  antigens  would  undoubtedly  also  be 
present in this antiserum. Adsorptions of the resulting antiserum with spleen or 
tumor cells of the target cell genotype (H-2  a) would thus be necessary, since in 
part  of  the  experiments  the  DBA/2  mastocytoma  (//-2  d)  cells  are  used  as 
targets. 
Titration of the Antiserum.--The initial studies in the characterization of this 
antiserum were involved in determining titers and kinetics of antibody-induced 
cytolysis. Normal C3H lymph node cells were labeled with  51Cr according to 
Berke's method of labeling tumor cells (16).  10 #1 of undiluted  serum (AS or 
NRS) were dispensed into 17  X  100-ram Falcon tubes (no. 2051)  on ice along 
with 25 #1 of C' diluted 1 : 1 with PBS. 1 X  10 ~ 51Cr-labeled  cells in a volume of 
25 #l were then added to the tubes and incubated in a water bath at 37°C. At 
given time points, 1.5 ml of ice-cold PBS was added to triplicate tubes of both 
AS and NRS groups. The tubes were vortexed lightly and centrifuged at 600 X 
g  for 5  minutes  at  10°C.  1-ml aliquots  of the  supernates  were removed and 
counted in a gamma scintillation spectrometer. The results of these experiments 
are  shown  in  Fig.  2.  Maximal  release  of  51Cr from target  cells  under  these 
conditions occurred within 15 rain. 
Antiserum titrations were performed exactly as described above using dilu- 
tions of AS  and NRS in a  volume of 10 #1.  Incubations were carried out for 
20 rain in a  37°C  water bath. The results of these experiments are shown in 
Fig. 3. It can be seen that final AS dilutions of up to 1:200 were effective in 
destroying greater than 90 % of the labeled target cells under these conditions. 
Removal  of Antitarget Cell Antibodies by  Adsorption.--It  was  necessary to 
remove  antibodies  directed  against  BALB/c  antigens,  since  these  antigens 
(H-Y) would also be present on target cells used in the next step of the protocol, 
BALB/c spleen cell suspensions were treated with NH4C1 to remove red blood 
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FIG. 2. Kinetics of antibody-induced cytolysis, l0 s 51Cr-labeled  C3H lymph node cells  were 
incubated with unadsorbed AS (O--O), or NRS (A--A), for various lengths of time in a 
37°C water bath, and percent 5tCr released was determined. Points represent the means of 
triplicate samples in which the SE was less than 10% of the mean. 892  T-CELL  RECEPTORS  IN  CELL-MEDIATED  IMMUNITY 
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Fro. 3. Titration  of AS. Various dilutions of unadsorbed AS (O--O) or NRS  (A--Z~), 
plus complement  were tested for their ability to release 51Cr  from 105 labeled C3H lymph node 
cells. Incubations were carried out for 20 min in a 37°C water bath. Points represent means 
of quadruplicate samples in which the SE was less than 10% of the mean. 
cells and  washed  twice in  PBS.  Undiluted  AS  was then  adsorbed with  these 
cells (1 ml AS:  1 m! packed ceils) for 45 rnin on ice. The resulting serum was 
then  compared with unadsorbed AS and NRS in  the presence of C' for their 
ability to release 51Cr from labeled BALB/c lymphocytes. The results of these 
experiments  are  seen in  Fig.  4.  After  a  single  45-min  adsorption  procedure, 
essentially  all  of  the  C'-fixing antitarget  cell  reactivity was  removed.  In  all 
subsequent  experiments,  this  adsorption  procedure  was  performed  twice  to 
ensure  removal  of  other  noncomplement  fixing  classes  of  immunoglobulin 
which might be present and serve to cover target cell antigens. This adsorption 
should also function to remove antibodies against most mouse species-specific 
antigens. 
Blocking  Activity  of  AS  on  Cell-Mediated  Cytotoxicity.--Unadsorbed  and 
BALB/c cell adsorbed AS were then tested for their ability to block the in vitro 
lysis of DBA/2 target cells by C3H anti-BALB/c effector cells (Table I). Four 
independent  experiments  were  performed  utilizing  a  fresh  aliquot  of  C'-in- 
activated AS, either unadsorbed or adsorbed against BALB/c spleen cells just 
before the experiment. The conditions for cytotoxicity testing were as described 
in  the  Materials  and  Methods  section.  In experiment  1,  it  can  be seen  that 
unadsorbed  antiserum  completely inhibited  cell-mediated cytotoxicity. How- 
ever, it is possible  that  this  inhibition  is due  to  covering of antigens  on  the 
target cells,  rather  than  receptor sites on  the  effector cells.  Experiments  2-4 
clearly  demonstrate  a  dose-dependent  ir,  hibition  using  BALB/c  adsorbed 
antiserum in which greater than 95 %  inhibition  can be achieved with a  total 
AS dilution of 1:3 present during the cytotoxicity assay. ARTHUR  K.  KIMURA  893 
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FIG. 4.  Removal of C'-fixing antitarget cell reactivity by adsorption.  Unadsorbed rabbit 
AS and NRS were compared with antitarget cell adsorbed AS and NRS, for their ability to 
release 5tCr from 10 5 BALB/c target cells.  Antiserum adsorptions were done with BALB/c 
spleen cells at an adsorbing ratio of 1:1  (AS:packed cells).  The results represent the means 
of two separate experiments in which the SE was less than 10% of the mean. 
TABLE I 
Rabbit Anti-(C3tt  Anti-BALB/c)  Dose-Dependent Inhibition  of Cell-Mediated 
Cytotoxicity o~ C3H Anti-BALB/¥  Effector Cells 
Exp, 
Antiserum  % 51Cr released in the 
Effector cell  adsorbed  Total serum  presence off§ 
against  :*  dilution~t 
NRS  AS 
1  C3H anti-BALB/c  --  1: 26  22.3  0 
2  C3H anti-BALB/c  BALB/c  1:16  43.4  28.5 
3  C3H anti-BALB/c  BALB/c  1: 10  52.3  20.1 
4  C3H anti-BALB/c  BALB/c  1:3  19.2  0.9 
* Undiluted, C'-inactivated, AS was adsorbed with BALB/c spleen cells and the P815-X2 
mastocytoma, at a  ratio of 1:1  (antiserum:packed  cells)  for 45 mill on ice to remove anti- 
target cell antibodies. 
:~ Final serum dilution present during the cytotoxicity assay. 
§ 5  X  105 C3H anti-BALB/c effector cells were preincubated  with various dilutions of 
NRS or AS for 1.5 h on ice before to the addition of 104  5tCr-labeled PS15-X2 target cells. 
After the 4-h cytotoxicity assay, at an effector to target cell ratio of 50:1, percent 51Cr release 
was determined. Values represent the means of triplicate samples in which the SE was always 
less than 10% of the mean. 
Specificity  of Antibody-Induced  Inhibition  of Cell-Mediated  Cytotoxicity.--It 
was  then  of  interest  to  examine  the  specificity  of  this  antibody  dependent 
inhibition of cell-mediated cytotoxicity. The  ability of this AS  to  block  the  in 
vitro  cytotoxicity of C3H anti-C57BL/6  effector cells against EL-4 target cells 894  T-CELL  RECEPTORS  IN  CELL-MEDIATED  IMMUNITY 
TABLE II 
Specificity of Inhibition of Cell-Mediated Cytotoxicity by Rabbit A nti-(C3H Receptors  for 
BALB/c) Antiserum 
Exp. 
Antiserum adsorbed  % 6~Cr released in 
against:*  the presence of:§ 
~  Target cell~  Effector cell  ~  ~  ,am 
NRS  AS 
1  C3H anti-C57BL/6  +  +  --  EL-4  18.9  0 
2tl  C3H anti-BALB/c  +  +  +  P815-X2  10.5  0.6 
C3H anti-C57BL/6  +  +  +  EL-4  7.4  5.7 
3¶  C3H anti-BALB/c  +  +  +  P815-X2  12.3  1.8 
C3H anti-C57BL/6  +  +  +  EL-4  37.0  33.0 
* Undiluted AS was adsorbed with the indicated cell types at an adsorbing ratio of 1:1 
(antiserum:packed  ceils). All antiserum was adsorbed twice to remove antitarget cell anti- 
bodies against the H-2  d target, P815-X2, (once with BALB/c spleen cells and once with the 
P815-X2 tumor target). The antiserum was similarly adsorbed twice against the 1t-2  b antigens 
with C57BL/6 spleen cells and the EL-4 tumor target  cells. Adsorptions with immune cells 
were performed once under identical conditions. 
~/51Cr-labeled EL-4 and P815-X2 tumor targets were used to measure specific cytotoxicity 
of C3H anti-C57BL/6 and C3H anti-BALB/c effector cells, respectively. 
§ AS or NRS, adsorbed against the indicated cell types were preincubated with the effector 
cells for 2 h on ice before the addition of the ~lCr-labeled target cells. Percent 51Cr released 
was determined after the 4-h assay with an effector to target cell ratio of 50:1. Values repre- 
sent the means of triplicate samples in which the SE was less than 10% of the mean. 
[I Effector cells were generated in vitro in MLC. 
¶ Effector cells were sensitized in vivo. 
was thus tested (Exp. 1, Table II). In this experiment, the AS was also adsorbed 
against C57BL/6 spleen cells and the EL-4 target cells to remove any possible 
antitarget cell  antibodies. The  degree  of  inhibition of  this  reaction  was  es- 
sentially 100 % at an antiserum dilution of 1:3. This nonspecific inhibition  may 
be related to the Ka antigen of Sullivan et al. (17), which has been shown to be 
present on many strains of effector ceils but not on normal lymphocytes. The 
antigen(s) may be present at a high density on effector ceils and/or sufficiently 
close to the receptor units to cause the observed inhibition. Alternatively, C3H 
anti-BALB/c and C3H anti-C57BL/6 effector cells may share common regions 
in  their  recognition units,  and  antibodies directed  to  these  areas  could  be 
responsible for this inhibition. 
The final step in the preparation of  this AS was its adsorption with  C3H 
anti-C57BL/6  effector ceils, to see if antibodies against this cell type could be 
removed independently of  the  blocking activity towards  C3H  anti-BALB/c 
effector ceils. The AS was adsorbed against C3H anti-C57BL/6 immune cells 
at an adsorbing ratio of 1:1 (AS:packed ceils) for 45 min on ice. The results of 
such adsorptions on blocking activities are seen in the remaining experiments of ARTHUR K,  KIMURA  895 
Table II. In each of the experiments, the removal of antibody-induced blocking 
of  C3H  anti-C57BL/6  effector  cells  was  achieved  without  seriously  altering 
the  specific inhibition  against  C3H anti-BALB/c.  Each of these  experiments 
represents  totally separate  protocols,  from unadsorbed  AS  through  the  final 
adsorption with C3H anti-C57BL/6 cells. These experiments demonstrate that 
antibodies  present  in  this  AS  can  discriminate  idiotypic  differences  between 
the structure of the recognition units present on C3H lymphocytes immune to 
two different strains of mouse cells. 
Evidence for  Effector  Cell Blockade.--Other  experiments  were performed  to 
demonstrate  conclusively that  the  blocking  of  CMC  was  due  to  antibodies 
directed against the effector cell. As shown in Fig. 4, a single adsorption of the 
AS with  lymphoid cells  of the  target  cell  genotype was sufficient  to remove 
essentially all of the  C'-fixing antitarget  cell antibodies.  This adsorption pro- 
cedure was routinely performed twice on all batches of AS used in the inhibition 
studies. It was further shown that adsorptions with C3H anti-C57BL/6 effector 
cells  would  remove  nonspecific  blocking  reactivity  without  affecting  the  in- 
hibition imposed on C3H anti-BALB/c effector cells. A  necessary corollary of 
this  would  be  that  if  the  inhibition  were  due  only to antibodies  directed  at 
effector  T  lymphocytes,  a  further  adsorption  of  the  AS  against  C3H  anti- 
BALB/c effector cells should remove the inhibition.  Experiments of this  type 
were performed and the results of such an adsorption are shown in Table III. 
Further  evidence  against  covering of target  cell  antigens  as an alternative 
TABLE III 
Complae Removal of Antiserum  Inhibition  by Adsorption with C3H Anti-BA LB /c Effector Cdls 
Antiserum adsorbed against:* 
.-~.  ,  Effector cell*  ~ca  ~  ~ ~  "~,~  Targets  cell§ 
% a~Cr released in 
the presence  of:lJ 
NRS  AS 
C3H anti-C57BL/6  q-  -4-  -4-  --  EL-4  51.2  43.0 
C3H anti-BALB/c  +  +  -4-  --  P815-X2  19.4  7.9 
C3H anti-C57BL/6  -4-  +  -4-  -4-  EL4  56.9  53.8 
C3H anti-BALB/c  +  -4-  +  +  P815-X2  26.1  27.5 
* Effector cells were sensitized in vivo. 
:~ Antiserum adsorptions were performed at an adsorbing ratio of 1 : 1 (undiluted antiserum: 
packed  cells) for 45 min on ice with the indicated  cell types.  All antiserum  was adsorbed 
twice to remove anti-H-2 d antibodies, once with BALB/c spleen ceils and once with P815-X2 
tumor ceils. The resulting antiserum was then twice adsorbed to remove any anti-H-2 b anti- 
bodies, once with C57BL/6 spleen ceils and once with EL-4 tumor cells. 
§ El-4 is the syngeneic leukosis of C57BL/6 (H-2  b) and P815-X2 is the DBA/2 masto- 
cytoma (I1-2~), which represent  the specific targets  for C3H anti-C57BL/6  and C3H anti- 
BALB/c effector cells, respectively. 
]] AS or NRS were present at a final dilution of 1:3 during the cytotoxicity assay. 896  T-CELL  RECEPTORS  IN  CELL-MEDIATED  IMMUNITY 
explanation for the observed inhibition comes from the following experiment. 
51Cr-labeled  target  cells  (P815-X2)  were  preincubated  with  fully  adsorbed- 
undiluted  AS,  NRS,  or  FCS  for  1 h  on  ice  before cytotoxicity testing.  The 
target  cell  suspensions  were diluted  to  2 ml with  PBS  (total  AS  dilution  of 
1:40),  counted  using  trypan  blue,  centrifuged  and  resuspended  to  the  ap- 
propriate concentration  (106/ml)  in PBS plus 2 %  C'-inactivated FCS.  These 
target cell suspensions were then added  to the microtest wells containing  the 
C3H anti-BALB/c effector cells and taken through  the cytotoxicity assay. If 
the site of blockade was even slightly involved at  the  target cell,  one would 
expect to see some degree of inhibition in  the AS-treated cells.  The results of 
such an experiment (Table IV) fail to show such an inhibition. It can be argued, 
TABLE  IV 
Effect of Serum Pretreatment of Target Cells on Cell-Mediated Cytotoxicity 
Effector cell  Target cells pretreated  with:*  Percent cytotoxicity 
AS  NRS  FCS  resulting:~ 
+  --  --  31.2 
C3H  anti  BALB/c§  --  +  --  30.8 
--  --  +  32.4 
*  ~lCr-labeled P815-X2 target cells (H-g d) were preincubated with BALB/c-, C3H anti- 
C57BL/6-adsorbed AS, NRS, or FCS for 1 h on ice. The cells were washed once with PBS + 
2% C~-inactivated FCS, counted with  trypan  blue, and  suspended to a  concentration of 
106/ml. 10/~1 of the various serum pretreated  target cells were then mixed with 5 X  10 ~ 
C3H anti-BALB/c effector cells and taken through the cytotoxicity assay. 
:~ Percent cytotoxicity =  percent 51Cr released. 
§ Effector cells were sensitized in vivo. 
however,  that  such  blocking antibodies are removed by the  single wash  and 
therefore  are  of  no  consequence  to  the  cytotoxicity  assay.  Although  this 
criticism cannot be ruled  out,  it seems unlikely  that antitarget antibodies,  if 
present at all, and of such low affinity for target cell antigens could function to 
achieve the degree of inhibition seen in Table II. 
DISCUSSION 
That B  lymphocytes have antigen-binding  receptors has now been demon- 
strated  by  a  variety  of  experiments,  including  binding  to  antigen-coated 
columns  (18,  19),  direct  antigen  binding  visualization  studies  (20,  21)  and 
antigen-induced  selective suicide  (22,  23).  It is  generally conceded  that  the 
antigen receptor on B cells is a form of immunoglobulin (24,  26). 
On the other hand,  the nature of the antigen-recognition unit  on T  cells is 
less well understood  (27,  29).  Immunoglobulins are certainly very much more 
sparse  on T-cell  surfaces  than  on  B  cells  (30,  31);  nonetheless~  some  recent ARTHUR  K.  KI~URA  897 
evidence has been obtained in support of the notion that at least the helper T- 
cell receptor may be immunoglobulin (32, 33). 
Attempts at blocking T-cell activity by various antibodies to immunoglobu- 
lins have met with apparently contradictory results in different laboratories. 
Brondz et al.  (34)  were unable to block in vitro cell-mediated cytotoxicity of 
immune lymphocytes on target cells by rabbit antimouse IgG, IgM, and IgA. 
Similar attempts at inhibiting the transfer of delayed hypersensitivity or GvH 
reactivity could not be demonstrated by such antisera (34, 35).  Greaves et al. 
(36) found that anti-light-chain serum or its Fab fragment could suppress the 
mitogenic  response  to  tuberculin  as  well  as  the  mixed  leukocyte reaction, 
implying that the receptors involved in these reactions may have an immuno- 
globulin-like structure. In a  similar system, however, Koch and Nielsen (37) 
could not corroborate the results of Greaves et al. Mason and Warner (35) have 
reported partial inhibition oi GvH reactions and delayed hypersensitivity by 
antibodies specific for light chains of immunoglobulins but could not demon- 
strate a removal o5 inhibition with the addition of light chains. In view of recent 
evidence for B-cell proliferation in MLC (38),  the observed inhibition due to 
anti-light-chain antibodies may represent B-cell inactivation. Evidence related 
to the size and specificity of the determinant recognized by T  cells in allograft 
reactions stands in contrast to the immunoglobulin receptors of B cells (39-43). 
One approach to the identification and characterization of the T-cell receptor 
would be the production of a specific antireceptor antiserum. The only systema- 
tic attempt at the production of such an antiserum that has been reported in 
the  literature  has  been  carried  out by Ramseier and Lindenmann (8).  The 
protocol for the production of their antiserum involved injection of parental 
lymphocytes into semiallogeneic F1 hybrids. The rationale was that while the 
parental lymphocytes would have receptors for the alloantigens on the F1 cells, 
the F1  lymphocytes should not possess such receptors,  and  thus respond  by 
producing  an  antireceptor  antiserum.  While  this  idea  seems  conceptually 
sound,  the  evidence obtained so far regarding the  function of the  supposed 
antiserum is not compelling. The assay routinely used to measure the activity 
of this antiserum,  the PAR assay (9),  suggests that  the  antiserum may be 
specific  for some T-cell determinant. On the other hand, antiserum raised in 
this manner and titered in the PAR assay was tested in a number of laboratories 
and reported by Lindahl (10) to have no effect on T-cell reactivity in MLC, on 
allograft  survival,  cell-mediated  cytotoxicity in  vitro,  or  GvH  reactivity. 
Antibodies  specifically  directed  against  the  T-cell  antigen  receptor  might 
reasonably be expected to affect all of these known T-cell functions. 
The approach taken in the present study was to develop immunization and 
antiserum adsorption protocols selective for idiotypic differences in the recog- 
nition units of syngenetic effector lymphocytes immune to two different strains 
of mouse cells. Antiserum was successfully raised against the cell-surface ele- 
ments of one set of effector cells, including the specific recognition units. Anti- 898  T-CELL  RECEPTORS  IN  CELL-MEDIATED  IMMUNITY 
bodies to all other surface elements except the receptor units were then removed 
by adsorption with a second set of effector cells syngeneic to the first, but im- 
mune to a different set of alloantigens. An antiserum raised according to such a 
protocol can thus be directed to, and only to, structural differences in the recep- 
tor  units  which  distinguish  the  immunoreactivity of  two  such  effector cell 
populations. All other surface elements are by definition identical. The ability 
of antiserum raised in this manner to detect idiotypic differences in receptor 
structure confirms the validity of such an approach. Rabbit anti-(C3H receptors 
for BALB/c) antiserum can specifically block the in vitro cytotoxicity of C3H 
anti-BALB/c effector cells without inhibiting C3H anti-C57BL/6 effector cells. 
The demonstration of these specific antireceptor antibodies is dependent upon 
proper adsorption procedures as seen in Table II. 
Since the antiserum described here was raised in rabbit against mouse cells, 
it is extremely important to show that the blocking effect obtained is against 
the effector cell and not against the mouse target cells, since antibodies against 
the latter are known to block cell-mediated cytotoxicity (1-3). That the anti- 
serum described here does not block sites on the target cell is affirmed by the 
experiments shown in Fig. 4 and Tables III and IV. A single adsorption of the 
original antiserum was  sufficient to remove all  C'-fixing cytotoxic antibodies 
(Fig.  4).  Pretreatment of target cells with  antiserum  twice adsorbed in  this 
manner showed no inhibitory effect on their subsequent cytolysis by effector 
cells.  Finally,  the  inhibitory effect of  the  adsorbed  antiserum  is  essentially 
completely abolished by a final adsorption with just those effector cells used for 
raising  the  original  antiserum  (Table  III).  These  experiments  demonstrate 
conclusively that the site of blocking is on the effector cell, and not on the target 
cell. 
It seems entirely likely that the conditions described here for production of 
this  antiserum  may not  be  optimal.  Particularly  troublesome has  been  the 
necessity to use the antiserum at 1:3 dilutions after adsorption, which has led 
to its very rapid consumption. It is anticipated that continuing experience will 
lead to protocols yielding higher initial titers. 
The experiments reported here are concerned only with the production and 
characterization of the antireceptor unit antiserum. The potential application 
of such a  method for the production of a  specific antilymphocyte serum for 
transplantation must be evaluated. It will also be of particular interest to look 
for  cross-reactivity of  the  fully adsorbed  antiserum  with  various  suggested 
candidates for the receptor unit itself, such as different classes of immunoglobu- 
lin,  light  and  heavy chains.  Such  studies  are  currently underway and  will 
provide the basis for future communications. 
SUMMARY 
The present study describes a method for the production of a specific anti-T- 
cell receptor antiserum, and characteristics of its ability to block specific cell- ARTHUR  K.  KIM:'URA  899 
mediated  cytotoxicity  in vitro.  Immunization  and  antiserum  adsorption  pro- 
cedures were designed to select for idiotypic differences in the recognition units 
of C3H lymphocytes immune to two different strains of mouse cells, such that 
the reactivity of only one population  of effector cells is inhibited  by this anti- 
serum,  t~oth in vivo and in vitro sensitized effector T  cells are subject to this 
inhibition. That the site of the antiserum blockade is clearly on the effector cell 
and not on the target cell is demonstrated. 
The author wishes to thank Doctors W. R. Clark,  E. E. Sercarz, P. I. Terasaki, and B. 
Bonavida for helpful suggestions in the preparation of the manuscript. 
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